Qlife Holding AB (publ) (STO:QLIFE)
Sweden · Delayed Price · Currency is SEK 4.000
+0.530 (15.27%)
Jul 16, 2025, 5:29 PM CET
Qlife Holding AB Company Description
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden.
The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software.
Its biomarkers include CRP/C-reactive protein, procalcitonin, Nt-pro-BNP, lipids, HbA1c/D-vitami, and D-dimer.
Qlife Holding AB (publ) was incorporated in 2019 and is based in Helsingborg, Sweden.
Qlife Holding AB (publ)
| Country | Sweden |
| Founded | 2019 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Thomas Warthoe |
Contact Details
Address: Redaregatan 48 Helsingborg, 252 36 Sweden | |
| Phone | 45 21 63 35 34 |
| Website | qlifeholding.com |
Stock Details
| Ticker Symbol | QLIFE |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0013486552 |
| SIC Code | 3821 |
Key Executives
| Name | Position |
|---|---|
| Thomas Warthoe | Co-Founder and Chief Executive Officer |
| Lars Bangsgaard | Co-Founder and Chief Financial Officer |
| Peter Warthoe | Co-Founder and Chief Scientific Officer |